Afinitor and Rashes - a phase IV clinical study of FDA data
Summary:
Rashes is found among people who take Afinitor, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Afinitor and have Rashes. It is created by eHealthMe based on reports of 39,807 people who have side effects when taking Afinitor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
39,807 people reported to have side effects when taking Afinitor.
Among them, 2,725 people (6.85%) have Rashes.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 39,878 Afinitor users for its effectiveness, alternative drugs and more.
What is Rashes?
Rashes (redness) is found to be associated with 4,984 drugs and 5,950 conditions by eHealthMe.
Number of Afinitor and Rashes reports submitted per year:
Time on Afinitor when people have Rashes *:
Gender of people who have Rashes when taking Afinitor*:
Age of people who have Rashes when taking Afinitor *:
Common drugs people take besides Afinitor *:
Common side effects people have besides Rashes *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Afinitor and have Rashes?
Check whether Rashes is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Rashes and when was it recovered:
Expand to all the drugs that have ingredients of everolimus:
- Rashes and drugs with ingredients of everolimus (3,020 reports)
Alternative drugs to, pros and cons of Afinitor:
- Afinitor (39,878 reports)
Common Afinitor side effects:
- Death: 5,716 reports
- Fatigue (feeling of tiredness): 4,180 reports
- Diarrhea: 3,836 reports
- Breathing difficulty: 2,776 reports
- Rashes (redness): 2,725 reports
- Pneumonia: 2,409 reports
Browse all side effects of Afinitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zRashes treatments and more:
- Rashes (603,793 reports)
COVID vaccines that are related to Rashes:
- Rashes in Moderna COVID Vaccine
- Rashes in Pfizer BioNTech Covid Vaccine
- Rashes in Johnson and Johnson Covid Vaccine
Common drugs associated with Rashes:
- Adapalene: 49,040 reports
- Humira: 32,791 reports
- Prednisone: 31,608 reports
- Methotrexate: 30,738 reports
- Enbrel: 29,268 reports
- Green tea: 21,666 reports
- Aspirin: 20,316 reports
- Revlimid: 15,559 reports
- Dupixent: 14,713 reports
- Orencia: 13,951 reports
All the drugs that are associated with Rashes:
- Rashes (4,984 drugs)
Common conditions associated with Rashes:
- Rheumatoid arthritis: 43,719 reports
- Acne: 29,888 reports
- High blood pressure: 18,830 reports
- Multiple sclerosis: 17,166 reports
- Multiple myeloma: 16,619 reports
- Psoriasis: 16,584 reports
- Pain: 12,270 reports
All the conditions that are associated with Rashes:
- Rashes (5,950 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Benzonatate and Confusion Aggravated - 3 seconds ago
- Foscavir and Cardiac Disorder - 33 seconds ago
- Propacet 100 and Back Pain Aggravated - 42 seconds ago
- Cubicin and Diarrhea Aggravated - 43 seconds ago
- Ketorolac Tromethamine vs. Stadol - a minute ago
- Neupro and Drug Exposure During Pregnancy - a minute ago
- Augmentin '125' and Menopausal Symptoms Aggravated - a minute ago
- How effective is Gabapentin for Complex Regional Pain Syndrome? - a minute ago
- Namenda vs. Galantamine Hydrobromide - a minute ago
- Ibuprofen and Tobi Podhaler drug interaction - a minute ago